Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals, Inc. (RCKT) is a healthcare company (biotechnology) based in the United States. The share price is $2.10, down 2.78% on the day, which values the company at $234.49M. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$2.10−2.78% today
Market value
$234.49M
200-week average
$12.7083% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Rocket Pharmaceuticals, Inc. in more detail

RCKT trades at -1.3× next year's expected earnings. It sits 83% below its 200-week average of $12.70.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold RCKT, including Lee Ainslie (0.1% of the portfolio).

Superinvestors holding RCKT

1 of the investors tracked here report a position in their latest 13F filing.

Rocket Pharmaceuticals, Inc. (RCKT): questions and answers

What is Rocket Pharmaceuticals, Inc.'s market cap?

Rocket Pharmaceuticals, Inc. is valued at $234.49M at a share price of $2.10.

Is RCKT above its 200-week moving average?

No. RCKT is 83.5% below its 200-week average of $12.70. Long-term investors watch that line because strong companies rarely trade below it for long.

Does RCKT pay a dividend?

Rocket Pharmaceuticals, Inc. does not currently pay a regular dividend.

Which famous investors own RCKT?

In their latest quarterly filings, Lee Ainslie (0.1% of the portfolio) hold RCKT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Rocket Pharmaceuticals, Inc. (RCKT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RCKT

Underlying data: Yahoo Finance; company filings with the SEC.